NCCIH Featured Content


05/19/2017 01:16 PM
A Crescendo of Interest and Research in Music and Health

In this blog post, NCCIH Director of External Research Dr. Emmeline Edwards discusses NIH/NCCIH funding opportunities in music and art therapies.


05/19/2017 10:34 AM
NCCIH’s New Approach to Clinical Trials

In this blog post, NCCIH Director Dr. Josephine Briggs discusses new pathways for clinical trial funding.


05/09/2017 02:03 PM
Genetic Edge Compounds Issues Voluntary Nationwide Recall of GEC Laxoplex Dietary Supplement Capsules Due to Presence of Anabolic Steroids

Genetic Edge Compounds voluntarily recalls all lot codes distributed between February 2, 2015-May 2, 2017 of GEC Laxoplex dietary supplement capsules.


05/08/2017 04:25 PM
NCCIH Reissues Funding Initiatives for Phased Awards of Mechanistic Studies To Optimize Mind and Body Interventions

In this blog post, Dr. Wen Chen discusses two Program Announcements (PARs) that direct research attention toward investigating the mechanisms by which mind and body interventions might work, as well as strategies to optimize these interventions.


05/05/2017 11:23 AM
Dealing With Opiate Withdrawal (FTC Blog, Scam Alerts)

FTC says not to trust dietary supplements promoted for opiate withdrawal.


05/04/2017 04:03 PM
Finding Funding for the Building Blocks of Natural Product Clinical Trials

Find out more about a new series of funding opportunity announcements for investigator-initiated clinical trials, and register for this May 9 webinar: New NCCIH Funding Opportunities for Natural Products Clinical Trials.


05/04/2017 08:04 AM
Monkey Business Contains Hidden Drug Ingredient

FDA advises consumers not to purchase or use Monkey Business, a product promoted for sexual enhancement.


05/03/2017 02:58 PM
Dietary Supplements for Eye Conditions
Eye doctor giving an exam to a senior citizen

Eye conditions that can lead to permanent visual impairment or blindness—including age-related macular degeneration (AMD), cataracts, diabetic retinopathy, and glaucoma—are serious public health problems.


05/03/2017 10:06 AM
4 Things To Know About Dietary Supplements for Eye Conditions

Four important things to know about dietary supplements and eye diseases.


05/01/2017 11:09 AM
Uses and Misuses of Pilot Studies

In this blog post, Dr. Lanay Mudd discusses the purpose of pilot studies and points to NCCIH’s new “Framework for Developing and Testing Mind and Body Interventions.”


04/27/2017 12:12 PM
Autism: Beware of Potentially Dangerous Therapies and Products

One thing that is important to know about autism up front: There is no cure for autism. So, products or treatments claiming to “cure” autism do not work as claimed. The same is true of many products claiming to “treat” autism or autism-related symptoms. Some may carry significant health risks.

The Food and Drug Administration (FDA) plays an important role in warning these companies against making improper claims about their products’ intended use as a treatment or cure for autism or autism-related symptoms.

About Autism


04/26/2017 08:10 AM
Illegal Cancer Treatments: FDA Warning - Fraudulent Claims of Diagnosis, Treatment, Prevention or Cure

FDA issued warning letters to 14 U.S.-based companies illegally selling products that fraudulently claim to prevent, diagnose, treat or cure cancer.


04/21/2017 09:43 AM
Organic Herbal Supply Issue Voluntary Nationwide Recall Of All Lots Of Various Supplements For Male And Female Sexual Enhancement Due To Undeclared Tadalafil And Flibanserin

Organic Herbal Supply, Inc. recalls all lots of Uproar, Cummor, Zrect, Monkey Business, Xrect, Rectalis, Tornado, Zdaily, BigNHard, Enhancerol Natural Male Enhancement capsules.


04/19/2017 04:22 PM
Show Me the Money! Finding Funding to Study the Clinical Effects of Mind and Body Interventions

At NCCIH, we are working hard to let the research community know about our new approach to funding research with human subjects that focuses on the clinical effects of complementary health approaches.


04/19/2017 09:25 AM
The NIH Health Care Systems Research Collaboratory – New Funding Opportunities for Health Systems Researchers
  • Do you have an important health care research question that can be answered in a real-world setting?
  • Is it in a high-priority area for NCCIH pragmatic trials?
  • Is the intervention already being utilized?
  • Do you have experience conducting clinical research in partnership with health care systems?

04/18/2017 09:37 AM
Certain Homeopathic Teething Products: Recall - Confirmed Elevated Levels of Belladonna

FDA alerts consumers to voluntary recall of Hyland’s Baby Teething Tablets and Hyland’s Baby Nighttime Teething Tablets for belladonna.


04/13/2017 09:08 AM
Transitions in the Division of Extramural Activities

In this blog post, NCCIH Deputy Director Dr. David Shurtleff commends Dr. Martin Goldrosen, who is retiring, and Dr. Partap Khalsa, who has been appointed Director of the NCCIH Division of Extramural Activities.


04/12/2017 12:15 PM
NCCIH Hosts Three Informational Webinars for New Clinical Trial Funding Opportunities

NCCIH to host informational webinars in April and May, 2017, on clinical trial applications via new funding opportunities.


04/11/2017 01:40 PM
Mapping the Brain During Sleep Yields New Insights on Dreaming and Consciousness
Man Sleeping

A new study, supported in part by NCCIH, counters some long-held beliefs on sleep, dreaming, and other consciousness states.


04/11/2017 09:52 AM
New Model Yields Fuller Picture of the Brain in Pain
pain target symbol

NCCIH-supported researchers created a functional MRI-based (fMRI) model that provides new ways of understanding and evaluating the neurobiological components of pain.


04/05/2017 03:44 PM
Staff Changes in the Division of Extramural Research

In this blog post, Dr. Emmeline Edwards announces new NCCIH roles for Drs. Craig Hopp and Wen Chen.